Carolyn A Lacey1, Lauren L Keleher1, William J Mitchell2, Charles R Brown2, Jerod A Skyberg1. 1. Department of Veterinary Pathobiology, College of Veterinary Medicine Laboratory for Infectious Disease Research, University of Missouri, Columbia. 2. Department of Veterinary Pathobiology, College of Veterinary Medicine.
Abstract
BACKGROUND: Brucella species are facultative intracellular gram-negative bacteria that cause brucellosis, a common global zoonosis. Infection of the joints is the most common focal complication of brucellosis in humans. The purpose of this study was to identify mediators of focal inflammation during brucellosis. METHODS: Wild-type (WT) mice are naturally resistant to Brucella infection; therefore, we infected anti-interferon γ (IFN-γ)-treated, or IFN-γ(-/-) mice with Brucella to induce osteoarticular and musculoskeletal inflammation, as we previously described. Mice were infected intraperitoneally with Brucella melitensis, and the clinical course of disease, histopathologic changes, and cytokine levels were compared among groups. RESULTS: Rag1(-/-) mice (B- and T-cell deficient) and µMT(-/-) mice (B-cell deficient) developed paw inflammation at a similar rate and severity as WT mice following infection with B. melitensis and treatment with anti-IFN-γ. Joints from B. melitensis-infected IFN-γ(-/-) mice had markedly increased levels of CCR2 and CXCR2 ligands. While anti-IFN-γ-treated CCR2(-/-) and WT mice behaved similarly, anti-IFN-γ-treated CXCR2(-/-) or IFN-γ(-/-)/CXCR2(-/-) mice had strikingly reduced focal swelling relative to anti-IFN-γ-treated WT or IFN-γ(-/-) mice, respectively. Additionally, neutrophil recruitment was dependent on CXCR2. CONCLUSIONS: Adaptive immune cells and CCR2 are dispensable, while CXCR2 is necessary for Brucella-induced focal neutrophil recruitment and inflammation.
BACKGROUND: Brucella species are facultative intracellular gram-negative bacteria that cause brucellosis, a common global zoonosis. Infection of the joints is the most common focal complication of brucellosis in humans. The purpose of this study was to identify mediators of focal inflammation during brucellosis. METHODS: Wild-type (WT) mice are naturally resistant to Brucella infection; therefore, we infected anti-interferon γ (IFN-γ)-treated, or IFN-γ(-/-) mice with Brucella to induce osteoarticular and musculoskeletal inflammation, as we previously described. Mice were infected intraperitoneally with Brucella melitensis, and the clinical course of disease, histopathologic changes, and cytokine levels were compared among groups. RESULTS:Rag1(-/-) mice (B- and T-cell deficient) and µMT(-/-) mice (B-cell deficient) developed paw inflammation at a similar rate and severity as WT mice following infection with B. melitensis and treatment with anti-IFN-γ. Joints from B. melitensis-infected IFN-γ(-/-) mice had markedly increased levels of CCR2 and CXCR2 ligands. While anti-IFN-γ-treated CCR2(-/-) and WT mice behaved similarly, anti-IFN-γ-treated CXCR2(-/-) or IFN-γ(-/-)/CXCR2(-/-) mice had strikingly reduced focal swelling relative to anti-IFN-γ-treated WT or IFN-γ(-/-) mice, respectively. Additionally, neutrophil recruitment was dependent on CXCR2. CONCLUSIONS: Adaptive immune cells and CCR2 are dispensable, while CXCR2 is necessary for Brucella-induced focal neutrophil recruitment and inflammation.
Authors: Patricia L Podolin; Brian J Bolognese; James J Foley; Dulcie B Schmidt; Peter T Buckley; Katherine L Widdowson; Qi Jin; John R White; Judithann M Lee; Richard B Goodman; Tonja R Hagen; Osamu Kajikawa; Lisa A Marshall; Douglas W P Hay; Henry M Sarau Journal: J Immunol Date: 2002-12-01 Impact factor: 5.422
Authors: Jhimmy Talbot; Francine J Bianchini; Danilele C Nascimento; Rene D R Oliveira; Fabricio O Souto; Larissa G Pinto; Raphael S Peres; Jaqueline R Silva; Sergio C L Almeida; Paulo Louzada-Junior; Thiago M Cunha; Fernando Q Cunha; Jose C Alves-Filho Journal: Arthritis Rheumatol Date: 2015-07 Impact factor: 10.995
Authors: M M Barsante; T M Cunha; M Allegretti; F Cattani; F Policani; C Bizzarri; W L Tafuri; S Poole; F Q Cunha; R Bertini; M M Teixeira Journal: Br J Pharmacol Date: 2007-09-24 Impact factor: 8.739
Authors: E Gotuzzo; G S Alarcón; T S Bocanegra; C Carrillo; J C Guerra; I Rolando; L R Espinoza Journal: Semin Arthritis Rheum Date: 1982-11 Impact factor: 5.532
Authors: Philipp Kruger; Mona Saffarzadeh; Alexander N R Weber; Nikolaus Rieber; Markus Radsak; Horst von Bernuth; Charaf Benarafa; Dirk Roos; Julia Skokowa; Dominik Hartl Journal: PLoS Pathog Date: 2015-03-12 Impact factor: 6.823
Authors: Omar H Khalaf; Sankar P Chaki; Daniel G Garcia-Gonzalez; Thomas A Ficht; Angela M Arenas-Gamboa Journal: Infect Immun Date: 2019-05-21 Impact factor: 3.441
Authors: Omar H Khalaf; Sankar P Chaki; Daniel G Garcia-Gonzalez; Larry J Suva; Dana Gaddy; Angela M Arenas-Gamboa Journal: Infect Immun Date: 2020-03-23 Impact factor: 3.441